Eli Lilly (LLY) Stock Gets Dual Price Target Upgrades as Obesity Drug Demand Surges
TLDR JPMorgan raised its LLY price target to $1,400 from $1,300, keeping an Overweight rating RBC Capital lifted its target even higher to $1,500, maintaining an
2026/07/09